The Latest Breaking News from Bayer

The synthetic biology leader's healthy cash balance provides plenty of breathing room, but it won't last forever.

Glyphosate is a common pesticide ingredient and has been linked to a number of health conditions in humans

While the overturning of Roe v Wade has dominated headlines and sparked protests across the United States and elsewhere, it is not the only recent ruling to come from the highest court in America.

Most internet users are by now aware of the vulnerability of their personal data. When the news broke that tech companies misuse and manipulate our personal data, there was a widespread “techlash” against the corporate giants Facebook, Amazon and Google.

BWX Technologies Inc (NYSE:BWXT) subsidiary BWXT Medical Ltd. has entered a commercial agreement with Bayer AG (OTC:BAYRY) to supply high-purity Actinium-225 (Ac-225). Bayer will purchase high-purity Ac-225 from BWXT Medical at pre-determined prices. The parties expect supply to commence later this year. The above agreement follows the agreement reached by the parties in September 2021.…

Share prices generally are down, so why not focus on something that works: dividend stocks? That's helped Europac International Dividend Income Fund.

Why the controversial herbicide glyphosate, which some experts link to cancer, is under scrutiny once more

The Supreme Court has rejected Bayer's appeal to shut down thousands of lawsuits claiming that its Roundup weedkiller causes cancer.

New York (AFP) - Stock markets rose Tuesday as calm returned following last week's rout, but analysts warned that recession fears have not gone away and will cause more turmoil.